Biosynth extends its offering to multi- kilogramme GMP peptide synthesis with acquisition of Pepceuticals
Biosynth, a supplier of critical materials to the life science industry, has acquired Pepceuticals, a UK producer of synthetic peptides with multi-kilogramme GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply.